Upon hearing about the war on drugs, many of us in medicine immediately become skeptical. Same old, same old—nothing seems to change. Yet this year, new healthcare codes for drug screening and intervention have been developed. Can these new efforts make a difference? Our guest today is Dr. Bertha Madras who serves as the Deputy Director of Demand Reduction in the White House office of National Drug Control Policy. Prior to this government post, she was Professor of Psychobiology in the Department of Psychiatry at Harvard Medical School. She is an expert on drug addiction and has authored over 130 papers and book chapters as well as receiving 16 patents.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
War on Drugs: New CPT codes for screening and RX
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Overview
Presenters
Recommended
Details
Presenters
Comments
Recommended
Overview
Upon hearing about the war on drugs, many of us in medicine immediately become skeptical. Same old, same old—nothing seems to change. Yet this year, new healthcare codes for drug screening and intervention have been developed. Can these new efforts make a difference? Our guest today is Dr. Bertha Madras who serves as the Deputy Director of Demand Reduction in the White House office of National Drug Control Policy. Prior to this government post, she was Professor of Psychobiology in the Department of Psychiatry at Harvard Medical School. She is an expert on drug addiction and has authored over 130 papers and book chapters as well as receiving 16 patents.
Presenters
Facebook Comments